Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian patients

Journal of Genetics

Volumn 90, Issue 1, 2011, Pages 161-163

  Gad, Mohamed Z ^a   Hassanein, Sally I ^a   Abdel Maksoud, Sahar M ^a   Shaban, Gamal M ^b   Abou Aisha, Khaled ^a  

^a German University in Cairo   (Egypt)

^b NATIONAL HEART INSTITUTE   (Egypt)

Author keywords

cardiovascular disease; DDAH2 gene polymorphism; Egyptians; human genetics

Indexed keywords

AMIDASE; DIMETHYLARGININASE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; EGYPT; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMIDOHYDROLASES; CARDIOVASCULAR DISEASES; EGYPT; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POPULATION;

EID: 79960150930     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-011-0043-4     Document Type: Article

References (13)

1. Afonina I., Zivarts M., Kutyavin I., Lukhtanov E., Gamper H. and Meyer R. B. 1997 Efficient priming of PCR with short oligonucleotides conjugated to a minor groove binder. Nucleic Acids Res. 25, 2657-2660.
2. Boger R. H. 2004 Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-Arginine Paradox" and acts as a novel cardiovascular risk factor. J. Nutr. 134, 2842-2847.
3. Dayoub H., Achan V., Adimoolam S., Jacobi J., Stuehlinger M. C., Wang B. Y. et al. 2003 Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation108, 3042-3047.
4. De Roy P. G. 2004 Helsinki and the declaration of helsinki. World Med. J. 50/1, 9-11.
5. Jones L. C. and Hingorani A. D. 2005 Genetic regulation of endothelial function. Heart91, 1275-1277.
6. Jones L. C., Tran C. T. L., Leiper J. M., Hingorani A. D. and Vallance P. 2003 Common genetic variation in a basal promoter element alters DDAH2 expression in endothelial cells. Biochem. Biophys. Res. Commun. 310, 836-843.
7. Kutyavin I. V., Lukhtano E. A., Gamper H. B. and Meyer R. B. 1997 Oligonucleotides with conjugated dihydropyrroloindole tripeptides: base composition and backbone effects on hybridization. Nucleic Acids Res. 25, 3718-3723.
8. Leiper J. M., Santa Maria J., Chubb A., MacAllister R. J., Charles I. G., Whitley G. S. et al. 1999 Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 343, 209-214.
9. Maas R., Erdmann J., Lüneburg N., Stritzke J., Schwedhelm E., Meisinger C. et al. 2009 Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension. Pharmacol. Res. 60, 488-493.
10. O'Dwyer M. J., Dempsey F., Crowley V., Dermot P., Kelleher D. P., Ross McManus R. et al. 2006 Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Crit. Care10, 139.
11. Tran C. T. L., Fox M. F., Vallance P. and Leiper J. H. 2000 Chromosomal localization, gene structure, and expression pattern of DDAH1: comparison with DDAH2 and implications for evolutionary origins. Genomics68, 101-105.
12. Vallance P., Leone A., Calver A., Collier J. and Moncada S. 1992 Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet339, 572-575.
13. Wang D., Gill P. S., Chabrashvili T., Onozato M. L., Raggio J., Mendonca M. et al. 2007 Isoform-specific regulation by N(G), N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO. Circ. Res. 101, 627-635.